Search

everythinglearnresearchcommunity

for

Search:↓

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

COVID-19 mRNA vaccines may increase the risk of flare-ups in certain inflammatory diseases.

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Activating TLR3 improves the healing and immune properties of periodontal ligament stem cells.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Calancardin B may help reduce inflammation in immune cells.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Inflammation helps stem cells repair tissue by directing their behavior.

Activating cannabinoid receptor 1 may help manage psoriasis by reducing certain keratins.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

NIPP1 is important for healthy skin and could help treat skin inflammation.

Inflammation may play a role in causing androgenetic alopecia.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.